Castle Biosciences (CSTL) Non Operating Income (2018 - 2026)

Castle Biosciences' (CSTL) quarterly Non Operating Income came in at -$439000.0 in Q1 2026, down 557.29% quarter-over-quarter from $96000.0 in Q4 2025.

Castle Biosciences (CSTL) Non Operating Income (2018 - 2026) Analysis & Trends

Castle Biosciences has disclosed Non Operating Income across 4 years of filings, most recently posting -$439000.0 for Q1 2026.

  • Non Operating Income for Q1 2026 came in at -$439000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$295000.0 (changed N/A YoY), and the FY2025 annual result was $144000.0, changed N/A from the prior year.
  • Non Operating Income came in at -$439000.0 for Q1 2026 at Castle Biosciences, down from $96000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $96000.0 in Q4 2025 to a low of -$439000.0 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn 1.00 Mn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -9.00 Mn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -73.00 Mn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn 21.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn 9.60 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -4.00 Mn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -52.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn 7.33 Mn
10 Castle Biosciences 629.76 Mn 368.04 Mn 63.15 Mn -439,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -439,000.00
Dec 31, 2025 96,000.00
Sep 30, 2025 48,000.00
Sep 30, 2019 -2.71 Mn
Jun 30, 2019 -189,000.00
Mar 31, 2019 -33,000.00
Dec 31, 2018 -242,544.00
Sep 30, 2018 -42,796.00
Jun 30, 2018 34,038.00